APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastritis Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gastritis Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025192 pages

Choose your research edition.

Industry ResearchGastritis Treatment Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastritis Treatment Drugs Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Gastritis Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastritis Treatment Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastritis Treatment Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Gastritis Treatment Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gastritis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gastritis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastritis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gastritis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastritis Treatment Drugs include Sun Pharmaceutical Industries, Novartis, Pfizer, AstraZeneca, Reddy's Laboratories, Perrigo Pharmaceutical, Microbiotix, Lupin Ltd and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gastritis Treatment Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gastritis Treatment Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gastritis Treatment Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gastritis Treatment Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Gastritis Treatment Drugs Segment by Company

Sun Pharmaceutical Industries

Novartis

Pfizer

AstraZeneca

Reddy's Laboratories

Perrigo Pharmaceutical

Microbiotix

Lupin Ltd

Cipla

Abbott Laboratories

Gastritis Treatment Drugs Segment by Type

Antibiotics

Antacids

Acid-Blocking Medicines

Histamine Blockers

Others

Gastritis Treatment Drugs Segment by Application

Hospitals

Clinics

Others

Gastritis Treatment Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastritis Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastritis Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastritis Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gastritis Treatment Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastritis Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gastritis Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gastritis Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gastritis Treatment Drugs Industry Trends Table 2. Gastritis Treatment Drugs Industry Drivers Table 3. Gastritis Treatment Drugs Industry Opportunities and Challenges Table 4. Gastritis Treatment Drugs Industry Restraints Table 5. Global Gastritis Treatment Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gastritis Treatment Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gastritis Treatment Drugs Sales by Manufacturers (W Tons) & (2021-2026) Table 8. Global Gastritis Treatment Drugs Sales Market Share by Manufacturers Table 9. Global Gastritis Treatment Drugs Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Gastritis Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gastritis Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gastritis Treatment Drugs Manufacturers, Product Type & Application Table 13. Global Gastritis Treatment Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gastritis Treatment Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Antibiotics Table 17. Major Manufacturers of Antacids Table 18. Major Manufacturers of Acid-Blocking Medicines Table 19. Major Manufacturers of Histamine Blockers Table 20. Major Manufacturers of Others Table 21. Global Gastritis Treatment Drugs Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 22. Global Gastritis Treatment Drugs Sales by Type (2021-2026) & (W Tons) Table 23. Global Gastritis Treatment Drugs Sales by Type (2027-2032) & (W Tons) Table 24. Global Gastritis Treatment Drugs Sales Market Share by Type (2021-2026) Table 25. Global Gastritis Treatment Drugs Sales Market Share by Type (2027-2032) Table 26. Global Gastritis Treatment Drugs Revenue by Type 2021 VS 2025 VS 2032 (W Tons) Table 27. Global Gastritis Treatment Drugs Revenue by Type (2021-2026) & (W Tons) Table 28. Global Gastritis Treatment Drugs Revenue by Type (2027-2032) & (W Tons) Table 29. Global Gastritis Treatment Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Gastritis Treatment Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospitals Table 32. Major Manufacturers of Clinics Table 33. Major Manufacturers of Others Table 34. Global Gastritis Treatment Drugs Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 35. Global Gastritis Treatment Drugs Sales by Application (2021-2026) & (W Tons) Table 36. Global Gastritis Treatment Drugs Sales by Application (2027-2032) & (W Tons) Table 37. Global Gastritis Treatment Drugs Sales Market Share by Application (2021-2026) Table 38. Global Gastritis Treatment Drugs Sales Market Share by Application (2027-2032) Table 39. Global Gastritis Treatment Drugs Revenue by Application 2021 VS 2025 VS 2032 (W Tons) Table 40. Global Gastritis Treatment Drugs Revenue by Application (2021-2026) & (W Tons) Table 41. Global Gastritis Treatment Drugs Revenue by Application (2027-2032) & (W Tons) Table 42. Global Gastritis Treatment Drugs Revenue Market Share by Application (2021-2026) Table 43. Global Gastritis Treatment Drugs Revenue Market Share by Application (2027-2032) Table 44. Global Gastritis Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 45. Global Gastritis Treatment Drugs Sales by Region (2021-2026) & (W Tons) Table 46. Global Gastritis Treatment Drugs Sales Market Share by Region (2021-2026) Table 47. Global Gastritis Treatment Drugs Sales Forecasted by Region (2027-2032) & (W Tons) Table 48. Global Gastritis Treatment Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Gastritis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 50. North America Gastritis Treatment Drugs Sales by Country (2021-2026) & (W Tons) Table 51. North America Gastritis Treatment Drugs Sales by Country (2027-2032) & (W Tons) Table 52. Europe Gastritis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 53. Europe Gastritis Treatment Drugs Sales by Country (2021-2026) & (W Tons) Table 54. Europe Gastritis Treatment Drugs Sales by Country (2027-2032) & (W Tons) Table 55. Asia Pacific Gastritis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 56. Asia Pacific Gastritis Treatment Drugs Sales by Country (2021-2026) & (W Tons) Table 57. Asia Pacific Gastritis Treatment Drugs Sales by Country (2027-2032) & (W Tons) Table 58. South America, Middle East and Africa Gastritis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 59. South America, Middle East and Africa Gastritis Treatment Drugs Sales by Country (2021-2026) & (W Tons) Table 60. South America, Middle East and Africa Gastritis Treatment Drugs Sales by Country (2027-2032) & (W Tons) Table 61. Global Gastritis Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Gastritis Treatment Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Gastritis Treatment Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Gastritis Treatment Drugs Revenue Market Share by Region (2021-2026) Table 65. Global Gastritis Treatment Drugs Revenue Market Share by Region (2027-2032) Table 66. Sun Pharmaceutical Industries Company Information Table 67. Sun Pharmaceutical Industries Business Overview Table 68. Sun Pharmaceutical Industries Gastritis Treatment Drugs Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sun Pharmaceutical Industries Gastritis Treatment Drugs Product Portfolio Table 70. Sun Pharmaceutical Industries Recent Development Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Gastritis Treatment Drugs Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Novartis Gastritis Treatment Drugs Product Portfolio Table 75. Novartis Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Gastritis Treatment Drugs Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Pfizer Gastritis Treatment Drugs Product Portfolio Table 80. Pfizer Recent Development Table 81. AstraZeneca Company Information Table 82. AstraZeneca Business Overview Table 83. AstraZeneca Gastritis Treatment Drugs Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. AstraZeneca Gastritis Treatment Drugs Product Portfolio Table 85. AstraZeneca Recent Development Table 86. Reddy's Laboratories Company Information Table 87. Reddy's Laboratories Business Overview Table 88. Reddy's Laboratories Gastritis Treatment Drugs Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Reddy's Laboratories Gastritis Treatment Drugs Product Portfolio Table 90. Reddy's Laboratories Recent Development Table 91. Perrigo Pharmaceutical Company Information Table 92. Perrigo Pharmaceutical Business Overview Table 93. Perrigo Pharmaceutical Gastritis Treatment Drugs Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Perrigo Pharmaceutical Gastritis Treatment Drugs Product Portfolio Table 95. Perrigo Pharmaceutical Recent Development Table 96. Microbiotix Company Information Table 97. Microbiotix Business Overview Table 98. Microbiotix Gastritis Treatment Drugs Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Microbiotix Gastritis Treatment Drugs Product Portfolio Table 100. Microbiotix Recent Development Table 101. Lupin Ltd Company Information Table 102. Lupin Ltd Business Overview Table 103. Lupin Ltd Gastritis Treatment Drugs Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Lupin Ltd Gastritis Treatment Drugs Product Portfolio Table 105. Lupin Ltd Recent Development Table 106. Cipla Company Information Table 107. Cipla Business Overview Table 108. Cipla Gastritis Treatment Drugs Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Cipla Gastritis Treatment Drugs Product Portfolio Table 110. Cipla Recent Development Table 111. Abbott Laboratories Company Information Table 112. Abbott Laboratories Business Overview Table 113. Abbott Laboratories Gastritis Treatment Drugs Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Abbott Laboratories Gastritis Treatment Drugs Product Portfolio Table 115. Abbott Laboratories Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Gastritis Treatment Drugs Distributors List Table 119. Gastritis Treatment Drugs Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Gastritis Treatment Drugs Product Image Figure 2. Global Gastritis Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastritis Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastritis Treatment Drugs Sales (2021-2032) & (W Tons) Figure 5. Global Gastritis Treatment Drugs Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Gastritis Treatment Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Antibiotics Image Figure 9. Antacids Image Figure 10. Acid-Blocking Medicines Image Figure 11. Histamine Blockers Image Figure 12. Others Image Figure 13. Global Gastritis Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 14. Global Gastritis Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Gastritis Treatment Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Gastritis Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 17. Global Gastritis Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Gastritis Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 19. Hospitals Image Figure 20. Clinics Image Figure 21. Others Image Figure 22. Global Gastritis Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 23. Global Gastritis Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Gastritis Treatment Drugs Sales Market Share by Application (2021-2032) Figure 25. Global Gastritis Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 26. Global Gastritis Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Gastritis Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 29. North America Gastritis Treatment Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 31. Canada Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 32. Mexico Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 33. Europe Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 34. Europe Gastritis Treatment Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 36. France Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 37. U.K. Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 38. Italy Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 39. Netherlands Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 40. Asia Pacific Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 41. Asia Pacific Gastritis Treatment Drugs Sales Market Share by Country (2021-2032) Figure 42. China Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 43. Japan Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 44. South Korea Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 45. Southeast Asia Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 46. India Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 47. Australia Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 48. South America, Middle East and Africa Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 49. South America, Middle East and Africa Gastritis Treatment Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 51. South Africa Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 52. Saudi Arabia Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 53. Turkey Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 54. Argentina Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 55. UAE Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 56. Egypt Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 57. Chile Gastritis Treatment Drugs Sales and Growth Rate (2021-2032) & (W Tons) Figure 58. Global Gastritis Treatment Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Gastritis Treatment Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Gastritis Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America Gastritis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Gastritis Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe Gastritis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Gastritis Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Gastritis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Gastritis Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Gastritis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Gastritis Treatment Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Gastritis Treatment Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Antibiotics
  • Antacids
  • Acid-Blocking Medicines
  • Histamine Blockers
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Sun Pharmaceutical Industries
  • Novartis
  • Pfizer
  • AstraZeneca
  • Reddy's Laboratories
  • Perrigo Pharmaceutical
  • Microbiotix
  • Lupin Ltd
  • Cipla
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gastritis Treatment Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gastritis Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gastritis Treatment Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gastritis Treatment Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gastritis Treatment Drugs Market Dynamics
  1. 2.1 Gastritis Treatment Drugs Industry Trends
  2. 2.2 Gastritis Treatment Drugs Industry Drivers
  3. 2.3 Gastritis Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Gastritis Treatment Drugs Industry Restraints
3 Gastritis Treatment Drugs Market by Manufacturers
  1. 3.1 Global Gastritis Treatment Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gastritis Treatment Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gastritis Treatment Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gastritis Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gastritis Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gastritis Treatment Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Gastritis Treatment Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gastritis Treatment Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gastritis Treatment Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gastritis Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Gastritis Treatment Drugs Market by Type
  1. 4.1 Gastritis Treatment Drugs Type Introduction
  2. 4.1.1 Antibiotics
  3. 4.1.2 Antacids
  4. 4.1.3 Acid-Blocking Medicines
  5. 4.1.4 Histamine Blockers
  6. 4.1.5 Others
  7. 4.2 Global Gastritis Treatment Drugs Sales by Type
  8. 4.2.1 Global Gastritis Treatment Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Gastritis Treatment Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Gastritis Treatment Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Gastritis Treatment Drugs Revenue by Type
  12. 4.3.1 Global Gastritis Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Gastritis Treatment Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Gastritis Treatment Drugs Revenue Market Share by Type (2021-2032)
5 Gastritis Treatment Drugs Market by Application
  1. 5.1 Gastritis Treatment Drugs Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Gastritis Treatment Drugs Sales by Application
  6. 5.2.1 Global Gastritis Treatment Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gastritis Treatment Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Gastritis Treatment Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Gastritis Treatment Drugs Revenue by Application
  10. 5.3.1 Global Gastritis Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gastritis Treatment Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Gastritis Treatment Drugs Revenue Market Share by Application (2021-2032)
6 Global Gastritis Treatment Drugs Sales by Region
  1. 6.1 Global Gastritis Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gastritis Treatment Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Gastritis Treatment Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Gastritis Treatment Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gastritis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gastritis Treatment Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gastritis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gastritis Treatment Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gastritis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gastritis Treatment Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gastritis Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gastritis Treatment Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gastritis Treatment Drugs Revenue by Region
  1. 7.1 Global Gastritis Treatment Drugs Revenue by Region
  2. 7.1.1 Global Gastritis Treatment Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gastritis Treatment Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Gastritis Treatment Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Gastritis Treatment Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gastritis Treatment Drugs Revenue (2021-2032)
  8. 7.2.2 North America Gastritis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gastritis Treatment Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Gastritis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gastritis Treatment Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gastritis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gastritis Treatment Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gastritis Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries
  2. 8.1.1 Sun Pharmaceutical Industries Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Gastritis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Gastritis Treatment Drugs Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Gastritis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Gastritis Treatment Drugs Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Gastritis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Gastritis Treatment Drugs Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Gastritis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Gastritis Treatment Drugs Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Reddy's Laboratories
  26. 8.5.1 Reddy's Laboratories Company Information
  27. 8.5.2 Reddy's Laboratories Business Overview
  28. 8.5.3 Reddy's Laboratories Gastritis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Reddy's Laboratories Gastritis Treatment Drugs Product Portfolio
  30. 8.5.5 Reddy's Laboratories Recent Developments
  31. 8.6 Perrigo Pharmaceutical
  32. 8.6.1 Perrigo Pharmaceutical Company Information
  33. 8.6.2 Perrigo Pharmaceutical Business Overview
  34. 8.6.3 Perrigo Pharmaceutical Gastritis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Perrigo Pharmaceutical Gastritis Treatment Drugs Product Portfolio
  36. 8.6.5 Perrigo Pharmaceutical Recent Developments
  37. 8.7 Microbiotix
  38. 8.7.1 Microbiotix Company Information
  39. 8.7.2 Microbiotix Business Overview
  40. 8.7.3 Microbiotix Gastritis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Microbiotix Gastritis Treatment Drugs Product Portfolio
  42. 8.7.5 Microbiotix Recent Developments
  43. 8.8 Lupin Ltd
  44. 8.8.1 Lupin Ltd Company Information
  45. 8.8.2 Lupin Ltd Business Overview
  46. 8.8.3 Lupin Ltd Gastritis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lupin Ltd Gastritis Treatment Drugs Product Portfolio
  48. 8.8.5 Lupin Ltd Recent Developments
  49. 8.9 Cipla
  50. 8.9.1 Cipla Company Information
  51. 8.9.2 Cipla Business Overview
  52. 8.9.3 Cipla Gastritis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cipla Gastritis Treatment Drugs Product Portfolio
  54. 8.9.5 Cipla Recent Developments
  55. 8.10 Abbott Laboratories
  56. 8.10.1 Abbott Laboratories Company Information
  57. 8.10.2 Abbott Laboratories Business Overview
  58. 8.10.3 Abbott Laboratories Gastritis Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Abbott Laboratories Gastritis Treatment Drugs Product Portfolio
  60. 8.10.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gastritis Treatment Drugs Value Chain Analysis
  2. 9.1.1 Gastritis Treatment Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gastritis Treatment Drugs Production Mode & Process
  6. 9.2 Gastritis Treatment Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gastritis Treatment Drugs Distributors
  9. 9.2.3 Gastritis Treatment Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst